Biogen and Sage Therapeutics' zuranolone has ... The biotech has another couple of recent approvals under its belt that have improved its outlook, however, including Aduhelm follow-up Leqembi ...

5:53 AM ESTHealth Care Sage rejects Biogen’s buyout offer, but says it's open to deals Sage rejects Biogen’s buyout offer, but says it's open to deals ...

Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making a comeback. After a lackluster showing in 2024 extended a yearslong ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Rob Lynch shares the fast-food chain’s growth strategies, including supply chain improvements, menu innovation and international expansion. He also discusses founder Danny Meyer’s support in advancing ...

A panel of farmers growing soybeans, milking cows and raising hens discuss how their businesses are feeling the impact of tariffs, natural disasters and the MAHA movement.